Dashboard
Manage Tickers

IMRXImmuneering Corp

Nasdaq immuneering.com


$ 1.58 $ -0.07 (-4.24 %)    

Tuesday, 07-May-2024 13:15:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.95 $ 1.43 (0.33 %)
DIA $ 389.00 $ -0.18 (-0.05 %)
SPY $ 517.81 $ 0.25 (0.05 %)
TLT $ 90.90 $ 0.05 (0.06 %)
GLD $ 214.44 $ -0.08 (-0.04 %)
$ 1.65
$ 1.64
$ 0.00 x 0
$ 1.59 x 100
$ 1.54 - $ 1.64
$ 1.38 - $ 11.92
315,097
na
46.89M
$ 0.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-01-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-06-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 09-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-buy-on-immuneering-maintains-15-price-target
Needham Reiterates Buy on Immuneering, Mai...
04/12/2024 10:33:08

Needham analyst Ami Fadia reiterates Immuneering (NASDAQ:IMRX) with a Buy and maintains $15 price target.

immuneering-presented-preclinical-data-at-aacr-annual-meeting-for-ongoing-phase-2a-clinical-trial-of-imm-1-104-in-ras-mutated-advanced-or-metastatic-solid-tumors
Immuneering Presented Preclinical Data At ...
04/09/2024 16:04:39

Globe Newswire- Preclinical data presented at AACR demonstrate that combining IMM-1-104 with chemotherapies used in the treatme...

immuneering-announces-first-patient-dosed-in-its-phase-12a-trial-of-imm-6-415-to-treat-advanced-solid-tumors-with-raf-or-ras-mutations
Immuneering Announces First Patient Dosed ...
03/27/2024 12:08:00

- Deep Cyclic Inhibitor of the MAPK pathway demonstrated strong tumor growth inhibition in preclinical studies of RAF or RAS mu...

why-science-applications-international-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
03/18/2024 18:37:43

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company r...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/18/2024 17:31:33

cancer-treatment-focused-immuneering-faces-analyst-downgrades-who-cite-underwhelming-solid-tumor-trial-data
Cancer Treatment Focused Immuneering Faces...
03/15/2024 19:29:25

Immuneering shares dip as analysts express concern over IMM-1-104 trial results. Needham downgrades, citing efficacy issues des...

dow-falls-over-200-points-adobe-shares-plunge
Dow Falls Over 200 Points; Adobe Shares Pl...
03/15/2024 18:40:28

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded...

why-jabil-shares-are-trading-lower-by-over-14-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Jabil Shares Are Trading Lower By Over...
03/15/2024 18:31:53

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter resu...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/15/2024 17:31:09

crude-oil-edges-lower-us-consumer-sentiment-falls-in-march
Crude Oil Edges Lower; US Consumer Sentime...
03/15/2024 16:05:34

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded do...

jefferies-downgrades-immuneering-to-hold-lowers-price-target-to-3
Jefferies Downgrades Immuneering to Hold, ...
03/15/2024 12:16:17

Jefferies analyst Michael Yee downgrades Immuneering (NASDAQ:IMRX) from Buy to Hold and lowers the price target from $16 to $3.

chardan-capital-maintains-buy-on-immuneering-lowers-price-target-to-16
Chardan Capital Maintains Buy on Immuneeri...
03/15/2024 11:20:09

Chardan Capital analyst Geulah Livshits maintains Immuneering (NASDAQ:IMRX) with a Buy and lowers the price target from $21 ...

needham-maintains-buy-on-immuneering-lowers-price-target-to-15
Needham Maintains Buy on Immuneering, Lowe...
03/15/2024 10:54:29

Needham analyst Ami Fadia maintains Immuneering (NASDAQ:IMRX) with a Buy and lowers the price target from $20 to $15.

td-cowen-downgrades-immuneering-to-market-perform
TD Cowen Downgrades Immuneering to Market ...
03/15/2024 08:52:02

TD Cowen analyst Yaron Werber downgrades Immuneering (NASDAQ:IMRX) from Outperform to Market Perform.

guggenheim-downgrades-immuneering-to-neutral
Guggenheim Downgrades Immuneering to Neutral
03/14/2024 20:09:10

Guggenheim analyst Michael Schmidt downgrades Immuneering (NASDAQ:IMRX) from Buy to Neutral.

why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Limbach Holdings Shares Are Trading Lo...
03/14/2024 17:38:41

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/14/2024 17:31:16

whats-going-on-with-cancer-focused-immuneering-stock-on-thursday
What's Going On With Cancer-Focused Immune...
03/14/2024 16:36:55

Unlock the latest Phase 1 trial results for IMM-1-104 by Immuneering. Discover how 320mg and 240mg doses inhibit tumor progress...

us-stocks-higher-producer-prices-rise-06-in-february
US Stocks Higher; Producer Prices Rise 0.6...
03/14/2024 13:46:43

U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow trad...

immuneering-shares-resume-trade
Immuneering Shares Resume Trade
03/14/2024 13:40:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION